0001493152-23-045524.txt : 20231220
0001493152-23-045524.hdr.sgml : 20231220
20231220094624
ACCESSION NUMBER: 0001493152-23-045524
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20231220
DATE AS OF CHANGE: 20231220
EFFECTIVENESS DATE: 20231220
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Coya Therapeutics, Inc.
CENTRAL INDEX KEY: 0001835022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-500218
FILM NUMBER: 231499679
BUSINESS ADDRESS:
STREET 1: 12645 MEMORIAL DR., SUITE F1 #305
CITY: HOUSTON
STATE: TX
ZIP: 77024
BUSINESS PHONE: 650.739.3939
MAIL ADDRESS:
STREET 1: 12645 MEMORIAL DR., SUITE F1 #305
CITY: HOUSTON
STATE: TX
ZIP: 77024
D
1
primary_doc.xml
X0708
D
LIVE
0001835022
Coya Therapeutics, Inc.
5850 SAN FELIPE ST.
SUITE 500
HOUSTON
TX
TEXAS
77057
650-739-3939
DELAWARE
None
None
Corporation
true
2020
Howard
Berman
5850 San Felipe St.
Suite 500
Houston
TX
TEXAS
77057
Executive Officer
Director
Fred
Grossman
5850 San Felipe St.
Suite 500
Houston
TX
TEXAS
77057
Executive Officer
David
Snyder
5850 San Felipe St.
Suite 500
Houston
TX
TEXAS
77057
Executive Officer
Dieter
Weinand
5850 San Felipe St.
Suite 500
Houston
TX
TEXAS
77057
Director
Anabella
Villalobos
5850 San Felipe St.
Suite 500
Houston
TX
TEXAS
77057
Director
Ann
Lee
5850 San Felipe St.
Suite 500
Houston
TX
TEXAS
77057
Director
Hideki
Garren
5850 San Felipe St.
Suite 500
Houston
TX
TEXAS
77057
Director
Dov
Goldstein
5850 San Felipe St.
Suite 500
Houston
TX
TEXAS
77057
Director
Wilbur
Ross
5850 San Felipe St.
Suite 500
Houston
TX
TEXAS
77057
Director
Biotechnology
Decline to Disclose
- 06b
false
2023-12-05
false
true
true
true
false
0
BTIG, LLC
122225
None
None
600 MONTGOMERY STREET
6TH FLOOR
SAN FRANCISCO
CA
CALIFORNIA
94111
All States
false
Newbridge Securities Corporation
104065
None
None
1200 NORTH FEDERAL HIGHWAY
SUITE 400
BOCA RATON
FL
FLORIDA
33432
All States
false
26484515
26484515
0
false
122
0
true
0
The Company paid BTIG and Newbridge a fee based on gross proceeds from the sale of securities placed by each placement agent respectively and issued to Newbridge a warrant exercisable for 196,168 shares of Common Stock.
0
true
Some of the proceeds may be used for working capital and general corporate purposes, including the payment of salaries and other fees to those listed in Item 3.
false
Coya Therapeutics, Inc.
/s/ Howard Berman
Howard Berman
Chief Executive Officer
2023-12-20